USDA Report

Showing 6054 articles
Business

Robinhood Markets: A Valuation Crossroads Amid Share Price Slump

Robinhood Markets (HOOD) shares face sustained pressure, creating a stark contrast with its reported strong annual revenue of $4.2 billion and net income of $2.2 billion. As investors weigh the disconnect, a prominent fair value estimate suggests significant upside, though lofty multiples and regulatory clouds loom.

Business

Merck Navigates Mixed Q4 2025 with Oncology Strength Offsetting Vaccine Slump, Sets Cautious 2026 Outlook

Merck & Co. reported a 5% rise in Q4 2025 revenue to $16.4 billion, powered by its blockbuster cancer drug Keytruda and animal health division. However, a steep 35% drop in Gardasil sales, attributed to weakened demand in Asia, highlighted regional vulnerabilities. The pharmaceutical giant issued initial 2026 guidance projecting modest growth while absorbing a significant one-time charge from its recent Cidara Therapeutics acquisition.